Publications by authors named "Mahasti Saghatchian"

36Publications

[Real-life study of 7-year survival in patients treated with trastuzumab for HER2+ early breast cancer].

Bull Cancer 2020 Jul - Aug;107(7-8):745-755. Epub 2020 Jun 10.

CRLCC François-Baclesse, department of medical oncology, Caen, France.

View Article and Find Full Text PDF
August 2020

[Management of side effects related to adjuvant hormone therapy in young women with breast cancer].

Bull Cancer 2019 Dec;106(12S1):S37-S42

Responsable PARCOURS SEIN, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France.

View Article and Find Full Text PDF
December 2019

[Impact of beauty and well-being care assessed in a national survey including 1166 individuals].

Bull Cancer 2018 Jul - Aug;105(7-8):671-678. Epub 2018 Jul 4.

Institut Bergonié, oncologie médicale, 229, cours de l'Argonne, 33076 Bordeaux, France.

View Article and Find Full Text PDF
August 2018

PARP Inhibitors in Breast Cancer: Why, How, and When?

Breast Care (Basel) 2018 Jul 20;13(3):216-219. Epub 2018 Jun 20.

Breast Cancer Unit, American Hospital of Paris, Neuilly-sur-Seine, France.

View Article and Find Full Text PDF
July 2018

[The pathologist 2.0.]

Ann Pathol 2017 Oct;37(5):345-346

Département de médecine oncologique, Gustave-Roussy, université Paris-Saclay, 114, rue Edouard-Vaillant, 94805 Villejuif, France. Electronic address:

View Article and Find Full Text PDF
October 2017

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

N Engl J Med 2016 Aug;375(8):717-29

From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

View Article and Find Full Text PDF
August 2016

Benchmarking facilities providing care: An international overview of initiatives.

SAGE Open Med 2015 23;3:2050312115601692. Epub 2015 Sep 23.

European and International Affairs, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF
January 2016

Actual costs of cancer drugs in 15 European countries.

Lancet Oncol 2016 Jan 4;17(1):18-20. Epub 2015 Dec 4.

The Cambridge Cancer Centre, Cambridge, UK.

View Article and Find Full Text PDF
January 2016

Identifying potential indicators to measure the outcome of translational cancer research: a mixed methods approach.

Health Res Policy Syst 2015 Dec 3;13:72. Epub 2015 Dec 3.

AP-HP, Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.

View Article and Find Full Text PDF
December 2015

[Molecular signatures of breast cancer: What clinical utility?].

Bull Cancer 2015 Jun;102(6 Suppl 1):S102-5

Department of medical oncology, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France; Inserm U981, Institut Gustave-Roussy 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France.

View Article and Find Full Text PDF
June 2015

[Trends and evolutions of French breast cancer research: a bibliometric study].

Bull Cancer 2015 May 14;102(5):417-27. Epub 2015 Apr 14.

Institut Gustave-Roussy, comité de pathologie mammaire, 114, rue Édouard-Vaillant, 94800 Villejuif, France.

View Article and Find Full Text PDF
May 2015